FDA Clears Expandable Lateral Lumbar Interbody Fusion System

Subscribe today to listen to this content Get Access

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to an expandable lateral lumbar interbody system.

Per the 510(k) statement, the device is indicated for “spinal fusion procedures in skeletally mature patients at one or two contiguous levels in the thoracolumbar spine.”